As part of MedCity’s 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has developed to detect SARS-CoV-2 and how the platform technology can be deployed to detect other diseases cost-effectively.
MedCity News publishes a series of important, powerful conversations on the business of healthcare with the help of key partners and sponsors.
Hear the latest industry news first. Sign up for our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
